[EN] END CAPPED NUCLEIC ACID MOLECULES<br/>[FR] MOLÉCULES D'ACIDE NUCLÉIQUE À EXTRÉMITÉ COIFFÉE
申请人:NOVARTIS AG
公开号:WO2016098028A1
公开(公告)日:2016-06-23
The disclosure relates to nucleic acids that contain modifications at the 5'-end, 3'-end or 5'-end and 3'-ends, and compounds that can be used to make the modified nucleic acids are disclosed. The modified nucleic acids have improved expression, lower immunogenicity and improved stability compared to unmodified nucleic acids.
The disclosure relates to nucleic acids that contain modifications at the 5'-end, 3'-end or 5'-end and 3'-ends, and compounds that can be used to make the modified nucleic acids are disclosed. The modified nucleic acids have improved expression, lower immunogenicity and improved stability compared to unmodified nucleic acids.The compounds are of formula (I)
3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA
申请人:NOVARTIS AG
公开号:US10676499B2
公开(公告)日:2020-06-09
The disclosure relates to nucleic acids that contain modifications at the 5′-end, 3′-end or 5′-end and 3′-ends, and compounds that can be used to make the modified nucleic acids are disclosed. The modified nucleic acids have improved expression, lower immunogenicity and improved stability compared to unmodified nucleic acids.
Preparation of substituted 2-pyridones by thermal rearrangement of propargylic pseudoureas. Improvements in the 2-pyridone yields by variations of the pseudourea NR2 substituent
作者:Larry E. Overman、Jan P. Roos
DOI:10.1021/jo00317a035
日期:1981.2
OVERMAN L. E.; TSUBOI S.; ROOS J. P.; TAYLOR G. F., J. AMER,. CHEM. SOC., 1980, 102, NO 2, 747-754
作者:OVERMAN L. E.、 TSUBOI S.、 ROOS J. P.、 TAYLOR G. F.